Drug price regulator NPPA on Tuesday announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and antibiotic, with a majority being reduced ahead of the GST implementation. The National Pharmaceutical Pricing Authority (NPPA) said however that the actual increase or decrease in prices after the roll out of new indirect tax regime is expected to be in be in the range of 2-3 per cent depending on states. “In order to facilitate smooth implementation of GST
Or View :
No comments:
Post a Comment